Tag: KumaMax

  • Translational Investigator awarded LSDF Matching Grant Award for Celiac Disease Therapy

                Please make a tax deductible donation at this LINK.  IPD Translational Investigator Dr. Ingrid Swanson Pultz was awarded a Matching Grant award of $250K from the Life Sciences Discovery Fund (LSDF) for her project ‘In vivo assessment of an oral therapeutic for celiac disease‘! We need to raise an additional $74K…

  • Seattle Health Innovators Visit the IPD

    The Seattle Health Innovators recently visited the Institute for Protein Design, and wrote a nice blog entitled “Crowdsourcing the design of new molecules to improve healthcare and the environment.”  The article provides a nice look into the Institute for Protein Design.  Learn more at this link.

  • KumaMax: Winner of C4C Recognition as a Novel Oral Therapeutic for Celiac Disease

      Dr. Ingrid Swanson Pultz, a Translational Investigator at the Institute for Protein Design won first prize at the UW Center for Commercialization 2013 Innovator Recognition Event, for KumaMax, an enzyme designed in the Baker lab to efficiently break down gluten within the acidic environment of the stomach, before it can reach the small intestine where intact gluten…